Marcus O Butler - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Marcus O Butler

Showing results (31-40 of 130) with videos related to

Pageof 13

Sort By:

MDM Policy & Practice|March 31, 2022

Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced MelanomaVictoria Federico Paly, Murat Kurt, Lirong Zhang, et al.

Journal of Autoimmunity|January 11, 2016

CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptorsKenji Chamoto, Tingxi Guo, Osamu Imataki, et al.

Journal for Immunotherapy of Cancer|February 29, 2024

Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapyAllison Betof Warner, Omid Hamid, Krishna Komanduri, et al.

JCO Oncology Practice|April 1, 2022

Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer CenterDiana Paola Arteaga Ceballos, Zaid Saeed-Kamil, Ian King, et al.

Journal of Autoimmunity|May 13, 2019

Chaperones of the class I peptide-loading complex facilitate the constitutive presentation of endogenous antigens on HLA-DP<sup>84GGPM87</sup>Mark Anczurowski, Kenji Sugata, Yukiko Matsunaga, et al.

Journal of Autoimmunity|October 16, 2018

Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cellsYuki Kagoya, Hiroshi Saijo, Yukiko Matsunaga, et al.

Cancer Immunology Research|January 30, 2016

Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic MelanomaLeila Khoja, Catherine Maurice, MaryAnne Chappell, et al.

Scientific Reports|April 1, 2016

CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cellsMunehide Nakatsugawa, Muhammed A Rahman, Yuki Yamashita, et al.

Cancer Immunology Research|April 24, 2020

Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell TherapyYuki Kagoya, Tingxi Guo, Brian Yeung, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007

Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cellMarcus O Butler, Jeng-Shin Lee, Sascha Ansén, et al.

Pageof 13

Search research articles

Showing results (31-40 of 130) with videos related to

Sort By:

Pageof 13

MDM Policy & Practice|March 31, 2022

Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced MelanomaVictoria Federico Paly, Murat Kurt, Lirong Zhang, et al.

Journal of Autoimmunity|January 11, 2016

CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptorsKenji Chamoto, Tingxi Guo, Osamu Imataki, et al.

Journal for Immunotherapy of Cancer|February 29, 2024

Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapyAllison Betof Warner, Omid Hamid, Krishna Komanduri, et al.

JCO Oncology Practice|April 1, 2022

Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer CenterDiana Paola Arteaga Ceballos, Zaid Saeed-Kamil, Ian King, et al.

Journal of Autoimmunity|May 13, 2019

Chaperones of the class I peptide-loading complex facilitate the constitutive presentation of endogenous antigens on HLA-DP<sup>84GGPM87</sup>Mark Anczurowski, Kenji Sugata, Yukiko Matsunaga, et al.

Journal of Autoimmunity|October 16, 2018

Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cellsYuki Kagoya, Hiroshi Saijo, Yukiko Matsunaga, et al.

Cancer Immunology Research|January 30, 2016

Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic MelanomaLeila Khoja, Catherine Maurice, MaryAnne Chappell, et al.

Scientific Reports|April 1, 2016

CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cellsMunehide Nakatsugawa, Muhammed A Rahman, Yuki Yamashita, et al.

Cancer Immunology Research|April 24, 2020

Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell TherapyYuki Kagoya, Tingxi Guo, Brian Yeung, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007

Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cellMarcus O Butler, Jeng-Shin Lee, Sascha Ansén, et al.

Pageof 13